Based on previously validated in vitro mechanistic data9–11 and the preliminary clinical evidence14, we hypothesized that high expression of CYP27A1 is associated with a better prognosis in premenopausal patients with ER+ breast cancer. This evidence concerns the gene CYP27A1 and breast carcinoma.